Zobrazeno 1 - 10
of 189
pro vyhledávání: '"William C, Duckworth"'
Autor:
Peter D, Reaven, Nicholas V, Emanuele, Wyndy L, Wiitala, Gideon D, Bahn, Domenic J, Reda, Madeline, McCarren, William C, Duckworth, Rodney A, Hayward, Virginia, Easton
Publikováno v:
New England Journal of Medicine. 380:2215-2224
BACKGROUND: We previously reported that a median of 5.6 years of intensive as compared with standard glucose lowering in 1791 military veterans with type 2 diabetes resulted in a risk of major cardiovascular events that was significantly lower (by 17
Autor:
Peter D. Reaven, Lizy Thottapurathu, Stephen N. Davis, Rodney A. Hayward, Nicholas V. Emanuele, Domenic J. Reda, William C. Duckworth, Wyndy L. Wiitala
Publikováno v:
Diabetes Care
OBJECTIVE To determine the risk factors for severe hypoglycemia and the association between severe hypoglycemia and serious cardiovascular adverse events and cardiovascular and all-cause mortality in the Veterans Affairs Diabetes Trial (VADT). RESEAR
Autor:
Mark B Zimering, Robert J Anderson, Ling eGe, Thomas E Moritz, William C Duckworth, Investigators for the VADT
Publikováno v:
Frontiers in Endocrinology, Vol 4 (2013)
Aim: Cardiovascular disease is a leading cause of morbidity and mortality in adults with type 2 diabetes mellitus. The aim of the present study was to test whether plasma basic fibroblast growth factor (bFGF) levels predict future cardiovascular dise
Externí odkaz:
https://doaj.org/article/03fe74da96f04e76b4bc4377e5a395dc
Publikováno v:
Postgraduate medicine. 96(3)
Preview Blindness, amputation, renal failure, premature coronary artery disease, disabling autonomic neuropathy: Most patients with type I diabetes mellitus must eventually confront one or more of these dire complications. However, carefully selected
Autor:
Rodney A. Hayward, William C. Duckworth, Domenic J. Reda, Wyndy L. Wiitala, Peter D. Reaven, Madeline McCarren, Ling Ge, Gideon Bahn, Nicholas V. Emanuele
Publikováno v:
New England Journal of Medicine. 372:2197-2206
BackgroundThe Veterans Affairs Diabetes Trial previously showed that intensive glucose lowering, as compared with standard therapy, did not significantly reduce the rate of major cardiovascular events among 1791 military veterans (median follow-up, 5
Autor:
Madeline McCarren, Ronald Klein, N. V. Emanuele, Peter D. Reaven, Nasrin Azad, Lily Agrawal, Rodney A. Hayward, Gideon D. Bahn, William C. Duckworth
Publikováno v:
Diabetes Care
OBJECTIVE To test the hypothesis that high levels of plasminogen-activating inhibitor (PAI)-1 and fibrinogen at baseline were associated with the onset or progression of diabetic retinopathy (DR) during the Veterans Affairs Diabetes Trial (VADT). RES
Autor:
Todd A. Conner, Robert F. Reilly, William C. Duckworth, Linda F. Fried, Peter A. McCullough, Stephen L. Seliger, Mary Brophy, Nicholas V. Emanuele, Paul M. Palevsky, Peter Guarino, Theresa Z. O'Connor, Suzanne Watnick, Jane H. Zhang, Stuart R. Warren, David J. Leehey, Peter Peduzzi
Publikováno v:
New England Journal of Medicine. 369:1892-1903
Background Combination therapy with angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) decreases proteinuria; however, its safety and effect on the progression of kidney disease are uncertain. Methods We provide
Autor:
William C, Duckworth, Carlos, Abraira, Thomas E, Moritz, Stephen N, Davis, Nicholas, Emanuele, Steven, Goldman, Rodney, Hayward, Grant D, Huang, Jennifer B, Marks, Peter D, Reaven, Domenic J, Reda, Stuart R, Warren, Franklin J, Zieve, Virginia, Easton
Publikováno v:
Journal of Diabetes and its Complications. 25:355-361
The goal of the VA Diabetes Trial (VADT) was to determine the effect of intensive glucose control on macrovascular events in subjects with difficult-to-control diabetes. No significant benefit was found. This report examines predictors of the effect
Autor:
Derrick G. Kaufman, Nicholas V. Emanuele, Gideon D. Bahn, Carlos Abraira, N. Azad, Thomas E. Moritz, William C. Duckworth, Lily Agrawal
Publikováno v:
Diabetes Care
OBJECTIVE The Veterans Affairs Diabetes Trial (VADT) was a randomized, prospective, controlled trial of 1,791 patients with type 2 diabetes to determine whether intensive glycemic control would reduce cardiovascular events compared with standard cont
Publikováno v:
Biochemical and Biophysical Research Communications. 402:762-766
Subjects with the metabolic syndrome (insulin resistance, glucose intolerance, dyslipidemia, hypertension, etc.) have a relative increase in abdominal fat tissue compared to normal individuals and obesity has also been shown to be associated with a d